4.5 Review

Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications

Journal

FEBS LETTERS
Volume 584, Issue 12, Pages 2670-2680

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.febslet.2010.04.014

Keywords

Affibody molecule; Alternative scaffold; Biotherapy; Molecular imaging; Combinatorial protein engineering; Phage display

Ask authors/readers for more resources

Affibody molecules are a class of engineered affinity proteins with proven potential for therapeutic, diagnostic and biotechnological applications. Affibody molecules are small (6.5 kDa) single domain proteins that can be isolated for high affinity and specificity to any given protein target. Fifteen years after its discovery, the Affibody technology is gaining use in many groups as a tool for creating molecular specificity wherever a small, engineering compatible tool is warranted. Here we summarize recent results using this technology, propose an Affibody nomenclature and give an overview of different HER2-specific Affibody molecules. Cumulative evidence suggests that the three helical scaffold domain used as basis for these molecules is highly suited to create a molecular affinity handle for vastly different applications. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available